Search results
- 1.4800Add to watchlist+0.0600 (+4.23%)At close: Tue. Sep 10, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed
- Open1.4200High1.4900Low1.4100
- Mkt Cap311.23MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close1.420052 Wk. Low0.780052 Wk. High2.4800
Related stocks
Aug 28, 2024 · Get a real-time Akebia Therapeutics, Inc. (AKBA) stock price quote with breaking news, financials, statistics, charts and more.
- 1.480-1.580
- 1.470
- 1.520
- 2,733,876
Aug 26, 2024 · Here, we discuss some reasons why buying Akebia (AKBA) stock now may turn out to be a prudent move.
Aug 26, 2024 · Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that its executives will ...
5 days ago · The 2 analysts with 12-month price forecasts for Akebia Therapeutics stock have an average target of 5.75, with a low estimate of 4.00 and a high estimate of 7.50. The average target predicts an increase of 325.93% from the current stock price of 1.35.
2 days ago · Should You Buy or Sell Akebia Therapeutics Stock? Get The Latest AKBA Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.
- (617) 871-2098
- 245 FIRST STREET SUITE 1100, CAMBRIDGE MA, 02142
- ir@akebia.com
5 days ago · AKBA's current price target is $5.75. Learn why top analysts are making this stock forecast for Akebia Therapeutics at MarketBeat.
People also ask
What does Akba stand for?
How much is Akebia Therapeutics (Akba) stock now?
Should I buy AKBA (Akba) stock?
What are analysts' Akba share price targets?
Sep 3, 2024 · Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted one newly-hired employee options to ...